Intensive cytotoxic bridging therapy before B-cell maturation antigen chimeric antigen receptor (CAR) T-cell therapy is associated with prolonged hematopoietic recovery and an increased risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results